nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—ADRB1—stomach cancer	0.241	0.366	CbGaD
Cabergoline—HTR1A—stomach cancer	0.215	0.327	CbGaD
Cabergoline—ADRB2—stomach cancer	0.202	0.307	CbGaD
Cabergoline—HTR7—myenteric nerve plexus—stomach cancer	0.00726	0.128	CbGeAlD
Cabergoline—HTR7—vagus nerve—stomach cancer	0.00484	0.0853	CbGeAlD
Cabergoline—HTR7—vein—stomach cancer	0.00468	0.0824	CbGeAlD
Cabergoline—HTR2A—myenteric nerve plexus—stomach cancer	0.00453	0.0798	CbGeAlD
Cabergoline—HTR2A—vagus nerve—stomach cancer	0.00302	0.0532	CbGeAlD
Cabergoline—HTR2A—vein—stomach cancer	0.00292	0.0514	CbGeAlD
Cabergoline—HTR1B—blood vessel—stomach cancer	0.00192	0.0339	CbGeAlD
Cabergoline—HTR1D—blood vessel—stomach cancer	0.00186	0.0328	CbGeAlD
Cabergoline—DRD5—hematopoietic system—stomach cancer	0.00166	0.0292	CbGeAlD
Cabergoline—HTR7—blood vessel—stomach cancer	0.00148	0.0262	CbGeAlD
Cabergoline—ADRA1D—epithelium—stomach cancer	0.00121	0.0214	CbGeAlD
Cabergoline—DRD5—lymphoid tissue—stomach cancer	0.00117	0.0205	CbGeAlD
Cabergoline—Pergolide—HTR1A—stomach cancer	0.00107	0.352	CrCbGaD
Cabergoline—Lisuride—ADRB1—stomach cancer	0.00104	0.342	CrCbGaD
Cabergoline—DRD5—endocrine gland—stomach cancer	0.000951	0.0168	CbGeAlD
Cabergoline—Lisuride—HTR1A—stomach cancer	0.000931	0.306	CrCbGaD
Cabergoline—HTR2A—blood vessel—stomach cancer	0.000926	0.0163	CbGeAlD
Cabergoline—HTR1A—hematopoietic system—stomach cancer	0.000827	0.0146	CbGeAlD
Cabergoline—HTR2B—smooth muscle tissue—stomach cancer	0.000813	0.0143	CbGeAlD
Cabergoline—HTR7—hematopoietic system—stomach cancer	0.000791	0.0139	CbGeAlD
Cabergoline—ADRA1D—endocrine gland—stomach cancer	0.000763	0.0134	CbGeAlD
Cabergoline—ADRA1A—hematopoietic system—stomach cancer	0.000763	0.0134	CbGeAlD
Cabergoline—HTR7—epithelium—stomach cancer	0.000723	0.0127	CbGeAlD
Cabergoline—ADRA1A—epithelium—stomach cancer	0.000697	0.0123	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—stomach cancer	0.000696	0.0123	CbGeAlD
Cabergoline—HTR2B—digestive system—stomach cancer	0.000642	0.0113	CbGeAlD
Cabergoline—ADRA2C—pancreas—stomach cancer	0.000592	0.0104	CbGeAlD
Cabergoline—HTR1B—endocrine gland—stomach cancer	0.000589	0.0104	CbGeAlD
Cabergoline—ADRA2A—hematopoietic system—stomach cancer	0.00058	0.0102	CbGeAlD
Cabergoline—ADRB1—endocrine gland—stomach cancer	0.000554	0.00977	CbGeAlD
Cabergoline—HTR7—digestive system—stomach cancer	0.00055	0.00969	CbGeAlD
Cabergoline—ADRA1A—lymphoid tissue—stomach cancer	0.000537	0.00946	CbGeAlD
Cabergoline—HTR2A—hematopoietic system—stomach cancer	0.000493	0.00869	CbGeAlD
Cabergoline—HTR1A—endocrine gland—stomach cancer	0.000475	0.00838	CbGeAlD
Cabergoline—ADRA2A—pancreas—stomach cancer	0.000472	0.00832	CbGeAlD
Cabergoline—CYP3A4—hematopoietic system—stomach cancer	0.000456	0.00804	CbGeAlD
Cabergoline—HTR7—endocrine gland—stomach cancer	0.000454	0.00801	CbGeAlD
Cabergoline—HTR2A—epithelium—stomach cancer	0.000451	0.00794	CbGeAlD
Cabergoline—ADRA1A—endocrine gland—stomach cancer	0.000438	0.00772	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—stomach cancer	0.000434	0.00765	CbGeAlD
Cabergoline—DRD2—endocrine gland—stomach cancer	0.000429	0.00757	CbGeAlD
Cabergoline—HTR7—liver—stomach cancer	0.00041	0.00722	CbGeAlD
Cabergoline—ADRA1A—liver—stomach cancer	0.000395	0.00696	CbGeAlD
Cabergoline—ADRA2C—liver—stomach cancer	0.000376	0.00663	CbGeAlD
Cabergoline—HTR2B—lymph node—stomach cancer	0.000367	0.00646	CbGeAlD
Cabergoline—HTR2A—digestive system—stomach cancer	0.000343	0.00604	CbGeAlD
Cabergoline—ADRA2A—endocrine gland—stomach cancer	0.000333	0.00587	CbGeAlD
Cabergoline—CYP3A4—digestive system—stomach cancer	0.000317	0.00559	CbGeAlD
Cabergoline—ADRA2C—lymph node—stomach cancer	0.000289	0.00509	CbGeAlD
Cabergoline—HTR2A—endocrine gland—stomach cancer	0.000283	0.00499	CbGeAlD
Cabergoline—CYP3A4—endocrine gland—stomach cancer	0.000262	0.00462	CbGeAlD
Cabergoline—HTR2A—liver—stomach cancer	0.000255	0.0045	CbGeAlD
Cabergoline—CYP3A4—liver—stomach cancer	0.000236	0.00417	CbGeAlD
Cabergoline—ADRA2A—lymph node—stomach cancer	0.00023	0.00406	CbGeAlD
Cabergoline—Abdominal pain—Irinotecan—stomach cancer	0.000195	0.00132	CcSEcCtD
Cabergoline—Feeling abnormal—Fluorouracil—stomach cancer	0.000194	0.00132	CcSEcCtD
Cabergoline—Bronchitis—Epirubicin—stomach cancer	0.000194	0.00132	CcSEcCtD
Cabergoline—Muscle spasms—Capecitabine—stomach cancer	0.000194	0.00132	CcSEcCtD
Cabergoline—Pneumonia—Methotrexate—stomach cancer	0.000194	0.00131	CcSEcCtD
Cabergoline—Depression—Methotrexate—stomach cancer	0.000192	0.0013	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—stomach cancer	0.000191	0.0013	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000188	0.00127	CcSEcCtD
Cabergoline—Ill-defined disorder—Capecitabine—stomach cancer	0.000187	0.00127	CcSEcCtD
Cabergoline—Syncope—Docetaxel—stomach cancer	0.000187	0.00127	CcSEcCtD
Cabergoline—Influenza—Doxorubicin—stomach cancer	0.000187	0.00127	CcSEcCtD
Cabergoline—Palpitations—Docetaxel—stomach cancer	0.000184	0.00125	CcSEcCtD
Cabergoline—Weight increased—Epirubicin—stomach cancer	0.000184	0.00125	CcSEcCtD
Cabergoline—Loss of consciousness—Docetaxel—stomach cancer	0.000183	0.00124	CcSEcCtD
Cabergoline—Weight decreased—Epirubicin—stomach cancer	0.000183	0.00124	CcSEcCtD
Cabergoline—Malaise—Capecitabine—stomach cancer	0.000182	0.00123	CcSEcCtD
Cabergoline—Epistaxis—Methotrexate—stomach cancer	0.000182	0.00123	CcSEcCtD
Cabergoline—Vertigo—Capecitabine—stomach cancer	0.000182	0.00123	CcSEcCtD
Cabergoline—Hypersensitivity—Irinotecan—stomach cancer	0.000182	0.00123	CcSEcCtD
Cabergoline—Syncope—Capecitabine—stomach cancer	0.000181	0.00123	CcSEcCtD
Cabergoline—Pneumonia—Epirubicin—stomach cancer	0.000181	0.00123	CcSEcCtD
Cabergoline—Hypertension—Docetaxel—stomach cancer	0.00018	0.00122	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—stomach cancer	0.00018	0.00122	CcSEcCtD
Cabergoline—Palpitations—Capecitabine—stomach cancer	0.000179	0.00121	CcSEcCtD
Cabergoline—Arthralgia—Docetaxel—stomach cancer	0.000178	0.0012	CcSEcCtD
Cabergoline—Loss of consciousness—Capecitabine—stomach cancer	0.000178	0.0012	CcSEcCtD
Cabergoline—Asthenia—Irinotecan—stomach cancer	0.000177	0.0012	CcSEcCtD
Cabergoline—Urinary tract infection—Epirubicin—stomach cancer	0.000175	0.00119	CcSEcCtD
Cabergoline—Hypertension—Capecitabine—stomach cancer	0.000174	0.00118	CcSEcCtD
Cabergoline—Hypersensitivity—Fluorouracil—stomach cancer	0.000174	0.00118	CcSEcCtD
Cabergoline—Dry mouth—Docetaxel—stomach cancer	0.000174	0.00118	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000174	0.00118	CcSEcCtD
Cabergoline—Arthralgia—Capecitabine—stomach cancer	0.000172	0.00116	CcSEcCtD
Cabergoline—Confusional state—Docetaxel—stomach cancer	0.000172	0.00116	CcSEcCtD
Cabergoline—Anxiety—Capecitabine—stomach cancer	0.000171	0.00116	CcSEcCtD
Cabergoline—Oedema—Docetaxel—stomach cancer	0.00017	0.00115	CcSEcCtD
Cabergoline—Weight increased—Doxorubicin—stomach cancer	0.00017	0.00115	CcSEcCtD
Cabergoline—Discomfort—Capecitabine—stomach cancer	0.00017	0.00115	CcSEcCtD
Cabergoline—Epistaxis—Epirubicin—stomach cancer	0.00017	0.00115	CcSEcCtD
Cabergoline—Weight decreased—Doxorubicin—stomach cancer	0.000169	0.00115	CcSEcCtD
Cabergoline—Diarrhoea—Irinotecan—stomach cancer	0.000169	0.00114	CcSEcCtD
Cabergoline—Dry mouth—Capecitabine—stomach cancer	0.000168	0.00114	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—stomach cancer	0.000168	0.00114	CcSEcCtD
Cabergoline—Shock—Docetaxel—stomach cancer	0.000168	0.00113	CcSEcCtD
Cabergoline—Pruritus—Fluorouracil—stomach cancer	0.000167	0.00113	CcSEcCtD
Cabergoline—Visual impairment—Methotrexate—stomach cancer	0.000166	0.00113	CcSEcCtD
Cabergoline—Confusional state—Capecitabine—stomach cancer	0.000166	0.00113	CcSEcCtD
Cabergoline—Oedema—Capecitabine—stomach cancer	0.000165	0.00112	CcSEcCtD
Cabergoline—Dizziness—Irinotecan—stomach cancer	0.000163	0.0011	CcSEcCtD
Cabergoline—Anorexia—Docetaxel—stomach cancer	0.000162	0.0011	CcSEcCtD
Cabergoline—Shock—Capecitabine—stomach cancer	0.000162	0.0011	CcSEcCtD
Cabergoline—Rhinitis—Epirubicin—stomach cancer	0.000162	0.0011	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—stomach cancer	0.000162	0.0011	CcSEcCtD
Cabergoline—Diarrhoea—Fluorouracil—stomach cancer	0.000161	0.00109	CcSEcCtD
Cabergoline—Cardiac disorder—Methotrexate—stomach cancer	0.00016	0.00109	CcSEcCtD
Cabergoline—Hyperhidrosis—Capecitabine—stomach cancer	0.000159	0.00108	CcSEcCtD
Cabergoline—Oedema peripheral—Epirubicin—stomach cancer	0.000159	0.00108	CcSEcCtD
Cabergoline—Hypotension—Docetaxel—stomach cancer	0.000159	0.00108	CcSEcCtD
Cabergoline—Epistaxis—Doxorubicin—stomach cancer	0.000157	0.00106	CcSEcCtD
Cabergoline—Anorexia—Capecitabine—stomach cancer	0.000157	0.00106	CcSEcCtD
Cabergoline—Vomiting—Irinotecan—stomach cancer	0.000157	0.00106	CcSEcCtD
Cabergoline—Dizziness—Fluorouracil—stomach cancer	0.000156	0.00106	CcSEcCtD
Cabergoline—Visual impairment—Epirubicin—stomach cancer	0.000156	0.00106	CcSEcCtD
Cabergoline—Rash—Irinotecan—stomach cancer	0.000155	0.00105	CcSEcCtD
Cabergoline—Dermatitis—Irinotecan—stomach cancer	0.000155	0.00105	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000155	0.00105	CcSEcCtD
Cabergoline—Headache—Irinotecan—stomach cancer	0.000154	0.00105	CcSEcCtD
Cabergoline—Hypotension—Capecitabine—stomach cancer	0.000154	0.00104	CcSEcCtD
Cabergoline—Insomnia—Docetaxel—stomach cancer	0.000154	0.00104	CcSEcCtD
Cabergoline—Paraesthesia—Docetaxel—stomach cancer	0.000153	0.00104	CcSEcCtD
Cabergoline—Alopecia—Methotrexate—stomach cancer	0.000153	0.00103	CcSEcCtD
Cabergoline—Dyspnoea—Docetaxel—stomach cancer	0.000152	0.00103	CcSEcCtD
Cabergoline—Somnolence—Docetaxel—stomach cancer	0.000151	0.00103	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00015	0.00102	CcSEcCtD
Cabergoline—Cardiac disorder—Epirubicin—stomach cancer	0.00015	0.00102	CcSEcCtD
Cabergoline—Vomiting—Fluorouracil—stomach cancer	0.00015	0.00102	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—stomach cancer	0.00015	0.00102	CcSEcCtD
Cabergoline—Dyspepsia—Docetaxel—stomach cancer	0.00015	0.00102	CcSEcCtD
Cabergoline—Insomnia—Capecitabine—stomach cancer	0.000149	0.00101	CcSEcCtD
Cabergoline—Rash—Fluorouracil—stomach cancer	0.000149	0.00101	CcSEcCtD
Cabergoline—Dermatitis—Fluorouracil—stomach cancer	0.000149	0.00101	CcSEcCtD
Cabergoline—Paraesthesia—Capecitabine—stomach cancer	0.000148	0.001	CcSEcCtD
Cabergoline—Decreased appetite—Docetaxel—stomach cancer	0.000148	0.001	CcSEcCtD
Cabergoline—Headache—Fluorouracil—stomach cancer	0.000148	0.001	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—stomach cancer	0.000147	0.000998	CcSEcCtD
Cabergoline—Dyspnoea—Capecitabine—stomach cancer	0.000147	0.000996	CcSEcCtD
Cabergoline—Fatigue—Docetaxel—stomach cancer	0.000147	0.000994	CcSEcCtD
Cabergoline—Nausea—Irinotecan—stomach cancer	0.000146	0.000991	CcSEcCtD
Cabergoline—Pain—Docetaxel—stomach cancer	0.000146	0.000986	CcSEcCtD
Cabergoline—Constipation—Docetaxel—stomach cancer	0.000146	0.000986	CcSEcCtD
Cabergoline—Back pain—Methotrexate—stomach cancer	0.000145	0.000985	CcSEcCtD
Cabergoline—Dyspepsia—Capecitabine—stomach cancer	0.000145	0.000983	CcSEcCtD
Cabergoline—Arrhythmia—Epirubicin—stomach cancer	0.000144	0.000978	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—stomach cancer	0.000144	0.000976	CcSEcCtD
Cabergoline—Decreased appetite—Capecitabine—stomach cancer	0.000143	0.000971	CcSEcCtD
Cabergoline—Alopecia—Epirubicin—stomach cancer	0.000143	0.000968	CcSEcCtD
Cabergoline—Fatigue—Capecitabine—stomach cancer	0.000142	0.000963	CcSEcCtD
Cabergoline—Constipation—Capecitabine—stomach cancer	0.000141	0.000955	CcSEcCtD
Cabergoline—Pain—Capecitabine—stomach cancer	0.000141	0.000955	CcSEcCtD
Cabergoline—Feeling abnormal—Docetaxel—stomach cancer	0.00014	0.00095	CcSEcCtD
Cabergoline—Nausea—Fluorouracil—stomach cancer	0.00014	0.000949	CcSEcCtD
Cabergoline—Ill-defined disorder—Methotrexate—stomach cancer	0.00014	0.000945	CcSEcCtD
Cabergoline—Gastrointestinal pain—Docetaxel—stomach cancer	0.000139	0.000943	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—stomach cancer	0.000139	0.00094	CcSEcCtD
Cabergoline—Flatulence—Epirubicin—stomach cancer	0.000139	0.000939	CcSEcCtD
Cabergoline—Tension—Epirubicin—stomach cancer	0.000138	0.000935	CcSEcCtD
Cabergoline—Nervousness—Epirubicin—stomach cancer	0.000137	0.000926	CcSEcCtD
Cabergoline—Back pain—Epirubicin—stomach cancer	0.000136	0.000922	CcSEcCtD
Cabergoline—Feeling abnormal—Capecitabine—stomach cancer	0.000136	0.00092	CcSEcCtD
Cabergoline—Malaise—Methotrexate—stomach cancer	0.000136	0.000919	CcSEcCtD
Cabergoline—Muscle spasms—Epirubicin—stomach cancer	0.000135	0.000916	CcSEcCtD
Cabergoline—Vertigo—Methotrexate—stomach cancer	0.000135	0.000915	CcSEcCtD
Cabergoline—Gastrointestinal pain—Capecitabine—stomach cancer	0.000135	0.000913	CcSEcCtD
Cabergoline—Abdominal pain—Docetaxel—stomach cancer	0.000135	0.000912	CcSEcCtD
Cabergoline—Arrhythmia—Doxorubicin—stomach cancer	0.000134	0.000905	CcSEcCtD
Cabergoline—Alopecia—Doxorubicin—stomach cancer	0.000132	0.000895	CcSEcCtD
Cabergoline—Ill-defined disorder—Epirubicin—stomach cancer	0.000131	0.000884	CcSEcCtD
Cabergoline—Abdominal pain—Capecitabine—stomach cancer	0.00013	0.000883	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—stomach cancer	0.000128	0.000869	CcSEcCtD
Cabergoline—Arthralgia—Methotrexate—stomach cancer	0.000128	0.000867	CcSEcCtD
Cabergoline—Tension—Doxorubicin—stomach cancer	0.000128	0.000866	CcSEcCtD
Cabergoline—Malaise—Epirubicin—stomach cancer	0.000127	0.00086	CcSEcCtD
Cabergoline—Discomfort—Methotrexate—stomach cancer	0.000127	0.000857	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—stomach cancer	0.000126	0.000857	CcSEcCtD
Cabergoline—Vertigo—Epirubicin—stomach cancer	0.000126	0.000856	CcSEcCtD
Cabergoline—Syncope—Epirubicin—stomach cancer	0.000126	0.000855	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—stomach cancer	0.000126	0.000853	CcSEcCtD
Cabergoline—Hypersensitivity—Docetaxel—stomach cancer	0.000125	0.00085	CcSEcCtD
Cabergoline—Muscle spasms—Doxorubicin—stomach cancer	0.000125	0.000848	CcSEcCtD
Cabergoline—Palpitations—Epirubicin—stomach cancer	0.000124	0.000842	CcSEcCtD
Cabergoline—Confusional state—Methotrexate—stomach cancer	0.000124	0.000838	CcSEcCtD
Cabergoline—Loss of consciousness—Epirubicin—stomach cancer	0.000124	0.000838	CcSEcCtD
Cabergoline—Asthenia—Docetaxel—stomach cancer	0.000122	0.000828	CcSEcCtD
Cabergoline—Hypertension—Epirubicin—stomach cancer	0.000122	0.000823	CcSEcCtD
Cabergoline—Hypersensitivity—Capecitabine—stomach cancer	0.000121	0.000823	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—stomach cancer	0.000121	0.000818	CcSEcCtD
Cabergoline—Pruritus—Docetaxel—stomach cancer	0.00012	0.000816	CcSEcCtD
Cabergoline—Arthralgia—Epirubicin—stomach cancer	0.00012	0.000812	CcSEcCtD
Cabergoline—Anxiety—Epirubicin—stomach cancer	0.000119	0.000809	CcSEcCtD
Cabergoline—Hyperhidrosis—Methotrexate—stomach cancer	0.000119	0.000804	CcSEcCtD
Cabergoline—Discomfort—Epirubicin—stomach cancer	0.000118	0.000802	CcSEcCtD
Cabergoline—Asthenia—Capecitabine—stomach cancer	0.000118	0.000801	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—stomach cancer	0.000117	0.000795	CcSEcCtD
Cabergoline—Dry mouth—Epirubicin—stomach cancer	0.000117	0.000794	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—stomach cancer	0.000117	0.000792	CcSEcCtD
Cabergoline—Anorexia—Methotrexate—stomach cancer	0.000117	0.000792	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—stomach cancer	0.000117	0.000791	CcSEcCtD
Cabergoline—Pruritus—Capecitabine—stomach cancer	0.000117	0.00079	CcSEcCtD
Cabergoline—Diarrhoea—Docetaxel—stomach cancer	0.000117	0.000789	CcSEcCtD
Cabergoline—Confusional state—Epirubicin—stomach cancer	0.000116	0.000784	CcSEcCtD
Cabergoline—Palpitations—Doxorubicin—stomach cancer	0.000115	0.000779	CcSEcCtD
Cabergoline—Oedema—Epirubicin—stomach cancer	0.000115	0.000778	CcSEcCtD
Cabergoline—Hypotension—Methotrexate—stomach cancer	0.000115	0.000777	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—stomach cancer	0.000114	0.000775	CcSEcCtD
Cabergoline—Shock—Epirubicin—stomach cancer	0.000113	0.000765	CcSEcCtD
Cabergoline—Diarrhoea—Capecitabine—stomach cancer	0.000113	0.000764	CcSEcCtD
Cabergoline—Dizziness—Docetaxel—stomach cancer	0.000113	0.000763	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—stomach cancer	0.000112	0.000761	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000112	0.000757	CcSEcCtD
Cabergoline—Hyperhidrosis—Epirubicin—stomach cancer	0.000111	0.000752	CcSEcCtD
Cabergoline—Insomnia—Methotrexate—stomach cancer	0.000111	0.000752	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—stomach cancer	0.000111	0.000751	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—stomach cancer	0.00011	0.000748	CcSEcCtD
Cabergoline—Paraesthesia—Methotrexate—stomach cancer	0.00011	0.000746	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—stomach cancer	0.00011	0.000742	CcSEcCtD
Cabergoline—Anorexia—Epirubicin—stomach cancer	0.000109	0.000742	CcSEcCtD
Cabergoline—Dyspnoea—Methotrexate—stomach cancer	0.000109	0.000741	CcSEcCtD
Cabergoline—Somnolence—Methotrexate—stomach cancer	0.000109	0.000739	CcSEcCtD
Cabergoline—Dizziness—Capecitabine—stomach cancer	0.000109	0.000738	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—stomach cancer	0.000108	0.000734	CcSEcCtD
Cabergoline—Vomiting—Docetaxel—stomach cancer	0.000108	0.000733	CcSEcCtD
Cabergoline—Dyspepsia—Methotrexate—stomach cancer	0.000108	0.000732	CcSEcCtD
Cabergoline—Rash—Docetaxel—stomach cancer	0.000107	0.000727	CcSEcCtD
Cabergoline—Hypotension—Epirubicin—stomach cancer	0.000107	0.000727	CcSEcCtD
Cabergoline—Dermatitis—Docetaxel—stomach cancer	0.000107	0.000727	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—stomach cancer	0.000107	0.000726	CcSEcCtD
Cabergoline—Decreased appetite—Methotrexate—stomach cancer	0.000107	0.000723	CcSEcCtD
Cabergoline—Headache—Docetaxel—stomach cancer	0.000107	0.000723	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—stomach cancer	0.000106	0.00072	CcSEcCtD
Cabergoline—Fatigue—Methotrexate—stomach cancer	0.000106	0.000717	CcSEcCtD
Cabergoline—Pain—Methotrexate—stomach cancer	0.000105	0.000711	CcSEcCtD
Cabergoline—Vomiting—Capecitabine—stomach cancer	0.000105	0.00071	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000105	0.000709	CcSEcCtD
Cabergoline—Shock—Doxorubicin—stomach cancer	0.000105	0.000708	CcSEcCtD
Cabergoline—Rash—Capecitabine—stomach cancer	0.000104	0.000704	CcSEcCtD
Cabergoline—Insomnia—Epirubicin—stomach cancer	0.000104	0.000704	CcSEcCtD
Cabergoline—Dermatitis—Capecitabine—stomach cancer	0.000104	0.000703	CcSEcCtD
Cabergoline—Headache—Capecitabine—stomach cancer	0.000103	0.0007	CcSEcCtD
Cabergoline—Paraesthesia—Epirubicin—stomach cancer	0.000103	0.000699	CcSEcCtD
Cabergoline—Hyperhidrosis—Doxorubicin—stomach cancer	0.000103	0.000696	CcSEcCtD
Cabergoline—Dyspnoea—Epirubicin—stomach cancer	0.000102	0.000694	CcSEcCtD
Cabergoline—Somnolence—Epirubicin—stomach cancer	0.000102	0.000692	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—stomach cancer	0.000101	0.000686	CcSEcCtD
Cabergoline—Nausea—Docetaxel—stomach cancer	0.000101	0.000685	CcSEcCtD
Cabergoline—Feeling abnormal—Methotrexate—stomach cancer	0.000101	0.000685	CcSEcCtD
Cabergoline—Dyspepsia—Epirubicin—stomach cancer	0.000101	0.000685	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methotrexate—stomach cancer	0.0001	0.00068	CcSEcCtD
Cabergoline—Decreased appetite—Epirubicin—stomach cancer	9.99e-05	0.000676	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—stomach cancer	9.93e-05	0.000673	CcSEcCtD
Cabergoline—Fatigue—Epirubicin—stomach cancer	9.9e-05	0.000671	CcSEcCtD
Cabergoline—Pain—Epirubicin—stomach cancer	9.82e-05	0.000665	CcSEcCtD
Cabergoline—Constipation—Epirubicin—stomach cancer	9.82e-05	0.000665	CcSEcCtD
Cabergoline—Nausea—Capecitabine—stomach cancer	9.79e-05	0.000663	CcSEcCtD
Cabergoline—Abdominal pain—Methotrexate—stomach cancer	9.7e-05	0.000657	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.68e-05	0.000656	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—stomach cancer	9.61e-05	0.000651	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—stomach cancer	9.54e-05	0.000646	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—stomach cancer	9.48e-05	0.000642	CcSEcCtD
Cabergoline—Feeling abnormal—Epirubicin—stomach cancer	9.47e-05	0.000641	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—stomach cancer	9.45e-05	0.00064	CcSEcCtD
Cabergoline—Gastrointestinal pain—Epirubicin—stomach cancer	9.39e-05	0.000636	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—stomach cancer	9.36e-05	0.000634	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—stomach cancer	9.24e-05	0.000626	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—stomach cancer	9.16e-05	0.000621	CcSEcCtD
Cabergoline—Pain—Doxorubicin—stomach cancer	9.09e-05	0.000616	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—stomach cancer	9.09e-05	0.000616	CcSEcCtD
Cabergoline—Abdominal pain—Epirubicin—stomach cancer	9.08e-05	0.000615	CcSEcCtD
Cabergoline—Hypersensitivity—Methotrexate—stomach cancer	9.04e-05	0.000612	CcSEcCtD
Cabergoline—Asthenia—Methotrexate—stomach cancer	8.81e-05	0.000596	CcSEcCtD
Cabergoline—Feeling abnormal—Doxorubicin—stomach cancer	8.76e-05	0.000593	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—stomach cancer	8.69e-05	0.000589	CcSEcCtD
Cabergoline—Pruritus—Methotrexate—stomach cancer	8.68e-05	0.000588	CcSEcCtD
Cabergoline—Hypersensitivity—Epirubicin—stomach cancer	8.46e-05	0.000573	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—stomach cancer	8.4e-05	0.000569	CcSEcCtD
Cabergoline—Diarrhoea—Methotrexate—stomach cancer	8.4e-05	0.000569	CcSEcCtD
Cabergoline—Asthenia—Epirubicin—stomach cancer	8.24e-05	0.000558	CcSEcCtD
Cabergoline—Pruritus—Epirubicin—stomach cancer	8.13e-05	0.00055	CcSEcCtD
Cabergoline—Dizziness—Methotrexate—stomach cancer	8.12e-05	0.00055	CcSEcCtD
Cabergoline—Diarrhoea—Epirubicin—stomach cancer	7.86e-05	0.000532	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—stomach cancer	7.83e-05	0.00053	CcSEcCtD
Cabergoline—Vomiting—Methotrexate—stomach cancer	7.8e-05	0.000529	CcSEcCtD
Cabergoline—Rash—Methotrexate—stomach cancer	7.74e-05	0.000524	CcSEcCtD
Cabergoline—Dermatitis—Methotrexate—stomach cancer	7.73e-05	0.000524	CcSEcCtD
Cabergoline—Headache—Methotrexate—stomach cancer	7.69e-05	0.000521	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—stomach cancer	7.63e-05	0.000516	CcSEcCtD
Cabergoline—Dizziness—Epirubicin—stomach cancer	7.6e-05	0.000514	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—stomach cancer	7.52e-05	0.000509	CcSEcCtD
Cabergoline—Vomiting—Epirubicin—stomach cancer	7.3e-05	0.000495	CcSEcCtD
Cabergoline—Nausea—Methotrexate—stomach cancer	7.29e-05	0.000494	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—stomach cancer	7.27e-05	0.000493	CcSEcCtD
Cabergoline—Rash—Epirubicin—stomach cancer	7.24e-05	0.000491	CcSEcCtD
Cabergoline—Dermatitis—Epirubicin—stomach cancer	7.24e-05	0.00049	CcSEcCtD
Cabergoline—Headache—Epirubicin—stomach cancer	7.2e-05	0.000487	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—stomach cancer	7.03e-05	0.000476	CcSEcCtD
Cabergoline—Nausea—Epirubicin—stomach cancer	6.82e-05	0.000462	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—stomach cancer	6.76e-05	0.000458	CcSEcCtD
Cabergoline—Rash—Doxorubicin—stomach cancer	6.7e-05	0.000454	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—stomach cancer	6.7e-05	0.000453	CcSEcCtD
Cabergoline—Headache—Doxorubicin—stomach cancer	6.66e-05	0.000451	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—stomach cancer	6.31e-05	0.000428	CcSEcCtD
Cabergoline—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.34e-06	2.49e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	3.33e-06	2.48e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—stomach cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCND1—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—stomach cancer	3.3e-06	2.45e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—JUN—stomach cancer	3.3e-06	2.45e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	3.29e-06	2.45e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RHOA—stomach cancer	3.28e-06	2.44e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK3—stomach cancer	3.28e-06	2.44e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	3.27e-06	2.43e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—KRAS—stomach cancer	3.27e-06	2.43e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCND1—stomach cancer	3.25e-06	2.42e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—stomach cancer	3.25e-06	2.42e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—JUN—stomach cancer	3.25e-06	2.42e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK3—stomach cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—stomach cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL8—stomach cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—stomach cancer	3.21e-06	2.39e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—stomach cancer	3.21e-06	2.39e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—HRAS—stomach cancer	3.2e-06	2.38e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	3.2e-06	2.38e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MYC—stomach cancer	3.19e-06	2.37e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL8—stomach cancer	3.17e-06	2.36e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—stomach cancer	3.16e-06	2.35e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—HRAS—stomach cancer	3.15e-06	2.34e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	3.15e-06	2.34e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CDKN1B—stomach cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MYC—stomach cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MYC—stomach cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—PIK3CA—stomach cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK1—stomach cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EGFR—stomach cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—stomach cancer	3.11e-06	2.32e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	3.1e-06	2.31e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	3.09e-06	2.3e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	3.09e-06	2.3e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	3.08e-06	2.3e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—STAT3—stomach cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK1—stomach cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EGFR—stomach cancer	3.07e-06	2.29e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EGFR—stomach cancer	3.07e-06	2.29e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	3.07e-06	2.29e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—stomach cancer	3.06e-06	2.28e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—STAT3—stomach cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—stomach cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	3.04e-06	2.26e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—stomach cancer	3.04e-06	2.26e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.03e-06	2.25e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—stomach cancer	3.02e-06	2.24e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—STAT3—stomach cancer	3.02e-06	2.24e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.01e-06	2.24e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—PIK3CA—stomach cancer	3e-06	2.24e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCND1—stomach cancer	3e-06	2.23e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—JUN—stomach cancer	2.99e-06	2.23e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.98e-06	2.22e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.98e-06	2.22e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.96e-06	2.2e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—stomach cancer	2.95e-06	2.2e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.95e-06	2.2e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.95e-06	2.19e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.95e-06	2.19e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.94e-06	2.19e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—JUN—stomach cancer	2.94e-06	2.19e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—KRAS—stomach cancer	2.94e-06	2.19e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.93e-06	2.18e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTP1—stomach cancer	2.92e-06	2.17e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.92e-06	2.17e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—stomach cancer	2.91e-06	2.17e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—stomach cancer	2.91e-06	2.16e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—KRAS—stomach cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—KRAS—stomach cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HRAS—stomach cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.89e-06	2.15e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HRAS—stomach cancer	2.88e-06	2.15e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.88e-06	2.15e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.87e-06	2.13e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.86e-06	2.13e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MYC—stomach cancer	2.86e-06	2.13e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.86e-06	2.13e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.85e-06	2.12e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.85e-06	2.12e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.84e-06	2.11e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.84e-06	2.11e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.83e-06	2.11e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HRAS—stomach cancer	2.82e-06	2.1e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.82e-06	2.1e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.81e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.81e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MYC—stomach cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.79e-06	2.08e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.79e-06	2.07e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HRAS—stomach cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—stomach cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—stomach cancer	2.77e-06	2.06e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—stomach cancer	2.76e-06	2.05e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MYC—stomach cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.73e-06	2.03e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.73e-06	2.03e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MYC—stomach cancer	2.73e-06	2.03e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TYMS—stomach cancer	2.72e-06	2.02e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.7e-06	2.01e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—stomach cancer	2.7e-06	2.01e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.69e-06	2e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTM1—stomach cancer	2.69e-06	2e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.68e-06	2e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.68e-06	2e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—PIK3CA—stomach cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.67e-06	1.98e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.67e-06	1.98e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—stomach cancer	2.66e-06	1.98e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.65e-06	1.97e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.65e-06	1.97e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—KRAS—stomach cancer	2.65e-06	1.97e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.62e-06	1.95e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—stomach cancer	2.62e-06	1.95e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.61e-06	1.95e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.61e-06	1.94e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.61e-06	1.94e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.6e-06	1.93e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—KRAS—stomach cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—STAT3—stomach cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—stomach cancer	2.58e-06	1.92e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.58e-06	1.92e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.57e-06	1.91e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—stomach cancer	2.54e-06	1.89e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.53e-06	1.88e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ERCC2—stomach cancer	2.52e-06	1.88e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.52e-06	1.87e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.52e-06	1.87e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HRAS—stomach cancer	2.5e-06	1.86e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.49e-06	1.86e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HRAS—stomach cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—KRAS—stomach cancer	2.45e-06	1.82e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.43e-06	1.81e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	2.43e-06	1.81e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.41e-06	1.79e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	2.41e-06	1.79e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MYC—stomach cancer	2.41e-06	1.79e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—stomach cancer	2.39e-06	1.78e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.38e-06	1.77e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	2.38e-06	1.77e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—stomach cancer	2.37e-06	1.77e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MYC—stomach cancer	2.37e-06	1.76e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—stomach cancer	2.36e-06	1.76e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.36e-06	1.76e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EGFR—stomach cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—stomach cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.34e-06	1.74e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—stomach cancer	2.33e-06	1.73e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.33e-06	1.73e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.32e-06	1.72e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.32e-06	1.72e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.32e-06	1.72e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.31e-06	1.72e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.31e-06	1.72e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—stomach cancer	2.3e-06	1.71e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.27e-06	1.69e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.27e-06	1.69e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	2.25e-06	1.67e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—stomach cancer	2.25e-06	1.67e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HRAS—stomach cancer	2.25e-06	1.67e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—stomach cancer	2.24e-06	1.67e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HRAS—stomach cancer	2.23e-06	1.66e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—KRAS—stomach cancer	2.22e-06	1.65e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.21e-06	1.65e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.21e-06	1.65e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HRAS—stomach cancer	2.2e-06	1.64e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAV1—stomach cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOA1—stomach cancer	2.18e-06	1.63e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—stomach cancer	2.18e-06	1.62e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—stomach cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.14e-06	1.59e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.14e-06	1.59e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.14e-06	1.59e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—stomach cancer	2.13e-06	1.59e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.11e-06	1.57e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—stomach cancer	2.11e-06	1.57e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.11e-06	1.57e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HRAS—stomach cancer	2.08e-06	1.55e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—stomach cancer	2.06e-06	1.53e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HRAS—stomach cancer	2.05e-06	1.53e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—stomach cancer	2.05e-06	1.52e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.04e-06	1.52e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.01e-06	1.5e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.99e-06	1.48e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.99e-06	1.48e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—stomach cancer	1.98e-06	1.47e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.97e-06	1.46e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.96e-06	1.46e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—stomach cancer	1.94e-06	1.45e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—stomach cancer	1.92e-06	1.43e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.9e-06	1.42e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HRAS—stomach cancer	1.89e-06	1.41e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.86e-06	1.38e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.83e-06	1.36e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.82e-06	1.35e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—stomach cancer	1.81e-06	1.35e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—stomach cancer	1.78e-06	1.32e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.77e-06	1.32e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.74e-06	1.3e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—stomach cancer	1.73e-06	1.29e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.69e-06	1.26e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—stomach cancer	1.66e-06	1.23e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.62e-06	1.2e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—stomach cancer	1.51e-06	1.13e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.31e-07	6.93e-06	CbGpPWpGaD
